Citations

Clear

5 citation(s) found for "Verbeeck, Christophe".

[P3–131]: ROLE OF TYPE 1 INTERFERON SIGNALLING ON PATHOGENIC TAU CLEARANCE
Das, Pritam , Carrano, Anna , Verbeeck, Christophe

Mayo Clinic

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_20 | Pages: No page available

10.1016/j.jalz.2017.06.1342 Get It

Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
Chakrabarty, Paramita , Jansen‐West, Karen , Beccard, Amanda, Ceballos‐Diaz, Carolina, Levites, Yona , Verbeeck, Christophe , Dickson, Dennis W. , Golde, Todd E. , Das, Pritam , Zubair, Abba C. , Dickson, Dennis W

Mayo Clinic

The FASEB Journal | October 14, 2009 | Volume: 24 | Issue: 2 | Pages: 548-559

10.1096/fj.09-141754 | PMID 19825975 Get It

Proinflammatory stimuli, after amyloid β (Aβ) deposition, have been hypothesized to create a self‐reinforcing positive feedback loop that increases amyloidogenic processing of the Aβ precursor protein (APP), promoting further Aβ accumulation and neuroinflammation in Alzheimer's disease (AD). Interleukin‐6 (IL‐6), a proinflammatory cytokine, has been shown to be increased in AD patients implying a pathological interaction. To assess the effects of IL‐6 on Aβ deposition and APP processing in vivo ,we overexpressed murine IL‐6 (mIL‐6) in the brains of APP transgenic TgCRND8 and TG2576 mice. mIL‐6 expression resulted in extensive gliosis and concurrently attenuated Aβ deposition in TgCRND8 mouse brains. This was accompanied by up‐regulation of glial phagocytic markers in vivo and resulted in enhanced microglia‐mediated phagocytosis of Aβ aggregates in vitro . Further, mIL‐6‐induced neuroinflammation had no effect on APP processing in TgCRND8 and had no effect on APP processing or steady‐state levels of Aβ in young Tg2576 mice. These results indicate that mIL‐6‐mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing Aβ plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology. This is the first study that methodically dissects the contribution of mIL‐6 with regard to its potential role in modulating Aβ deposition in vivo .—Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., Das, P. Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J . 24, 548–559 (2010). www.fasebj.org
P3‐354: Role of IL‐6‐mediated chronic neuroinflammation on amyloid pathology
Chakrabarty, Paramita , Nimcheski, Kasey, Golde, Todd E. , Verbeeck, Christophe , Das, Pritam , Jansen, Karen

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_19 | Pages: No page available

10.1016/j.jalz.2008.05.1924 Get It

P1‐052: Somatic brain transgenic TDP‐43 mice
Verbeeck, Christophe , Cannon-Crews, Ashley, Jansen‐West, Karen , Ceballos‐Diaz, Carolina, Golde, Todd E. , Kukar, Thomas , McGowan, Eileen

Mayo Clinic

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2008.05.638 Get It